JFCR, NEC and Taiho Partner on Whole-Genome Driven Cancer Vaccine Research
JFCR, NEC, and Taiho have launched a joint research initiative to develop novel cancer vaccines using whole-genome data. The project is part of AMED’s national programme on whole-genome analysis, supporting efforts to demonstrate its clinical utility and build systems that translate genomic insights into patient benefits.
Whole-genome Information | 01/12/2025 | By Dineshwori | 146
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy